Pediatric Lymphoma-Histiocytosis Fellowship
Pediatric hematology-oncology fellowship programs, such as that at Baylor College of Medicine and Texas Children’s Hospital, teach the basic principles and practice of care of pediatric patients with leukemia.
In order to enable interested physicians to acquire more comprehensive and advanced knowledge and skills in this subspecialty area, we developed a year of postgraduate training specifically in the area of pediatric lymphoma/histiocytosis at Baylor College of Medicine and Texas Children's Hospital.
Our pediatric lymphoma/histiocytosis team represents some of the nation’s most outstanding experts in the field of childhood lymphoma/histiocytic diseases. This setting provides the perfect environment for achieving these educational goals.
Goals and Objectives
- To develop clinical expertise, leadership skills and research expertise in the field of lymphoma and histiocytic diseases
- To provide advanced training in the evaluation, diagnosis, and management of children and adolescents with lyphoproliferative disorders, lymphoma and histiocytic diseases
- To augment administrative and clinical expertise in the multidisciplinary field of pediatric lymphoma/histiocytic diseases
- To improve the trainees’ knowledge of lymphoproliferative disorders, lymphoma and histiocytic disease biology in such a way that they will have a comprehensive understanding of this topic
- To train individuals in the current Phase I, II and III therapies of pediatric lymphoma and histiocytic such that they will have expertise in the clinical management of patients with this disease
- To further enhance the teaching and leadership skills of trainees in this area
- Candidates should be American Board of Pediatrics eligible for pediatric hematology-oncology or should have received equivalent training as judged by the program directors
- Only individuals who have successfully completed an ACGME-accredited fellowship in pediatric hematology-oncology or equivalent training are eligible for this advanced training opportunity
Foreign medical graduates and visa holders
At this time, we are only able to accept J-1 training visas, but not those with H1B visas.
July - June
Program Accreditation and Training Sites
- Texas Medical Board: 503-48-05-34
- Texas Children’s Hospital
- University of Texas M.D. Anderson Cancer Center
Through the following core rotations, each lasting for one to two months, the trainee will acquire multidisciplinary knowledge and skills necessary for the management of children and adolescents with lymphoma and histiocytic diseases. Depending on the rotation, the trainee will spend 2-3 days weekly in these learning venues in addition to the time spent in the lymphoma and histiocytosis clinic service as noted above. The trainee will participate in the following:
- Protocol development
- Flow Cytometry
The trainee will actively participate in several recurrent educational conferences:
- Tumor Board: Tuesday afternoons (1 hr)
- Texas Children's Cancer Center Departmental Research Seminar: Thursday mornings (1 hr)
- Fellow’s Reflective Practice and Leadership Seminar: twice a month (1.5 hr/session)
- Clinical and Research Mentor Meeting: weekly (1 hr)
- Journal Review (selected topic regarding dendritic, T-cell or NK cell biology, lymphoma or histiocytic disease ): (1 hr)
- Lymphoma/Histiocytosis Patient Radiology Review: weekly (1 hr)
- Lymphoma/Histiocytosis Pathology Review: weekly (1 hr)
- Histiocytosis Clinical Review: weekly (30 min)
- Lymphoma Team Meeting: weekly (1 hr)
- Laboratory Group Meeting: weekly (1 hr)
Program E-mail: firstname.lastname@example.org
Lymphoma-Histiocytosis Fellowship Clinical Director: Kenneth McClain, MD, PhD
Lymphoma-Histiocytosis Fellowship Program Director
YoungNa Lee-Kim, MD
Fellows interested in this fellowship training program must complete and submit an application along with three letters of reference, a curriculum vitae and a statement of interest. Learn more about how to apply for this fellowship.